Literature DB >> 22128899

Association study of CARD8 (p.C10X) and NLRP3 (p.Q705K) variants with rheumatoid arthritis in French and Tunisian populations.

M Ben Hamad1, F Cornelis, S Marzouk, G Chabchoub, Z Bahloul, A Rebai, F Fakhfakh, H Ayadi, E Petit-Teixeira, A Maalej.   

Abstract

The objective of the study was to investigate the association of caspase activating and recruitment domain 8 (CARD8) and nucleotide-binding oligomerization domain, leucine-rich repeat and pyrin domain containing 3 (NLRP3) polymorphisms with rheumatoid arthritis (RA) in Tunisian and French populations. CARD8 (c.30T>A, rs2043211) and NLRP3 (c.2113C>A, rs35829419) single nucleotide polymorphisms (SNPs) were genotyped in 100 French RA trio families and 141 Tunisian patients with RA and 191 unrelated healthy controls, using TaqMan(®) allelic discrimination assay. The genetic analyses for the association and linkage in French families were performed using the comparison of allelic frequencies (AFBAC), the genotype relative risk (GRR) and the transmission disequilibrium test (TDT). Data for case and control samples were analysed by chi-square-test, GRR and odds ratio (OR). No significant differences between alleles and genotypes frequencies were detected in French trio and Tunisian patients with RA and controls, either with CARD8 or with NLRP3 SNPs both in French and in Tunisian populations. Moreover, stratifying patients according to the presence of rheumatoid factor (RF), anti-cyclic peptides antibodies (ACPA), erosion, nodules, other autoimmune disease or HLA-DRB1*04-positive subgroups did not show any significant association with CARD8 or NLRP3 (P ≥ 0.05). This study suggests that variations in the innate immunity genes CARD8 (p.C10X) and NLRP3 (p.Q705K) have no effect on RA susceptibility either in the Tunisian or in the French population.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22128899     DOI: 10.1111/j.1744-313X.2011.01070.x

Source DB:  PubMed          Journal:  Int J Immunogenet        ISSN: 1744-3121            Impact factor:   1.466


  16 in total

1.  Polymorphisms and expression of inflammasome genes are associated with the development and severity of rheumatoid arthritis in Brazilian patients.

Authors:  Catarina Addobbati; Heidi Lacerda Alves da Cruz; José Eduardo Adelino; Amanda Luíze Melo Tavares Ramos; Thiago Sotero Fragoso; Alexandre Domingues; Ângela Luiza Branco Pinto Duarte; Renê Donizeti Ribeiro Oliveira; Paulo Louzada-Júnior; Eduardo Antônio Donadi; Alessandra Pontillo; Jaqueline de Azevêdo Silva; Sergio Crovella; Paula Sandrin-Garcia
Journal:  Inflamm Res       Date:  2017-12-11       Impact factor: 4.575

2.  Anti-inflammatory effect of omega unsaturated fatty acids and dialysable leucocyte extracts on collagen-induced arthritis in DBA/1 mice.

Authors:  Pamela I Pérez-Martínez; Oscar Rojas-Espinosa; Víctor G Hernández-Chávez; Patricia Arce-Paredes; Sergio Estrada-Parra
Journal:  Int J Exp Pathol       Date:  2020-05-27       Impact factor: 1.925

3.  NLRP3 gene variants and serum NLRP3 levels in periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome.

Authors:  Damla Kaynak; Mehmet Yildiz; Sezgin Sahin; Fatih Haslak; Aybuke Gunalp; Amra Adrovic; Kenan Barut; Mehmet Guven Gunver; Ozgur Kasapcopur; Selcuk Dasdemir
Journal:  Clin Rheumatol       Date:  2022-09-10       Impact factor: 3.650

Review 4.  Targeting inflammasomes in rheumatic diseases.

Authors:  Alexander So; Annette Ives; Leo A B Joosten; Nathalie Busso
Journal:  Nat Rev Rheumatol       Date:  2013-05-14       Impact factor: 20.543

5.  Inhibition of P2X4 suppresses joint inflammation and damage in collagen-induced arthritis.

Authors:  Faxin Li; Nongjian Guo; Yuxia Ma; Bin Ning; Yan Wang; Liqing Kou
Journal:  Inflammation       Date:  2014-02       Impact factor: 4.092

6.  NLRP3 Inflammasome Polymorphism and Macrovascular Complications in Type 2 Diabetes Patients.

Authors:  Jasna Klen; Katja Goričar; Andrej Janež; Vita Dolžan
Journal:  J Diabetes Res       Date:  2015-07-27       Impact factor: 4.011

7.  Negative regulation of the NLRP3 inflammasome by A20 protects against arthritis.

Authors:  Geert van Loo; Mohamed Lamkanfi; Lieselotte Vande Walle; Nina Van Opdenbosch; Peggy Jacques; Amelie Fossoul; Eveline Verheugen; Peter Vogel; Rudi Beyaert; Dirk Elewaut; Thirumala-Devi Kanneganti
Journal:  Nature       Date:  2014-06-29       Impact factor: 49.962

8.  NLRP3 and CARD8 Polymorphisms Influence Higher Disease Activity in Rheumatoid Arthritis.

Authors:  Barbara Jenko; Sonja Praprotnik; Matija Tomšic; Vita Dolžan
Journal:  J Med Biochem       Date:  2016-07-06       Impact factor: 3.402

9.  Enhanced activity of NLRP3 inflammasome in peripheral blood cells of patients with active rheumatoid arthritis.

Authors:  Christianna Choulaki; Garyfallia Papadaki; Argyro Repa; Eleni Kampouraki; Konstantinos Kambas; Konstantinos Ritis; George Bertsias; Dimitrios T Boumpas; Prodromos Sidiropoulos
Journal:  Arthritis Res Ther       Date:  2015-09-19       Impact factor: 5.156

10.  NLRP3 Inflammasome Plays an Important Role in the Pathogenesis of Collagen-Induced Arthritis.

Authors:  Yongfeng Zhang; Yi Zheng; Hongbin Li
Journal:  Mediators Inflamm       Date:  2016-03-02       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.